Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 no DAC & Ipamorelin vs Sermorelin: Protocol Comparison

Primary Mechanism GHRH receptor agonism only Dual-pathway: GHRH receptor + ghrelin receptor (GHS-R1a) The combination's dual-pathway activation delivers synergistic GH pulse amplitude that single-pathway protocols can't match Effective Half-Life 7–10 minutes C

This comparison does not assign a generated winner or score.

  • Primary Mechanism
  • GHRH receptor agonism only
  • Dual-pathway: GHRH receptor + ghrelin receptor (GHS-R1a)
  • The combination's dual-pathway activation delivers synergistic GH pulse amplitude that single-pathway protocols can't match
  • Effective Half-Life
  • 7–10 minutes
  • CJC-1295 no DAC: ~30 min; Ipamorelin: ~2 hours
  • Extended duration translates to fewer daily injections and more sustained IGF-1 elevation
  • Typical Dosing Frequency
  • 2–3 injections daily
  • Once daily (typically evening administration)
  • Once-daily protocols reduce handling complexity and contamination risk
  • Peak GH Pulse Amplitude
  • Baseline to 2–4× elevation
  • Baseline to 3–6× elevation (synergistic effect)
  • Higher peak amplitude correlates with greater downstream IGF-1 response
  • IGF-1 Response Timeline
  • Measurable increase within 2–3 weeks
  • Measurable increase within 10–14 days
  • Slightly faster IGF-1 elevation with combination, though both require 2+ weeks for meaningful changes
  • Side Effect Frequency
  • Mild: flushing, injection-site reactions, occasional headaches
  • Equivalent to Sermorelin despite higher GH output
  • Ipamorelin's selectivity prevents the cortisol/prolactin elevation seen with older ghrelin mimetics
  • Receptor Desensitisation Risk
  • Low (mimics natural pulsatility)
  • Low (dual pathways reduce single-receptor overstimulation)
  • Both protocols preserve natural feedback loops better than continuous-release formulations
  • Cost per Week (Typical)
  • Moderate (higher per-injection cost, more frequent dosing)
  • Moderate to high (lower injection frequency offsets per-dose cost)
  • Total weekly cost is comparable when factoring injection frequency
More references

Related material